Contact us

Virginia Contract Research Organization Co., Ltd.

 Founded in Taiwan in 1997, VCRO has expanded to China and the US. Specializing in contract clinical research for new drug development, VCRO excels in regenerative medicine and gene therapy. It is recognized as the most professional and experienced CRO in the Asia-Pacific region.

About us

U.S. FDA Releases Draft Guidance on Expedited Program for Serious Conditions-Accelerated Approval of Drugs and Biologics (Part 2.)

2025-04-01
Evidentiary Criteria for Accelerated ApprovalDrugs under accelerated approval must meet the same statutory standards for safety and effectiveness as those…
Read More

U.S. FDA Releases Draft Guidance on Expedited Program for Serious Conditions-Accelerated Approval of Drugs and Biologics (Part 1.)

2025-03-24
In December 2024, the U.S. Food and Drug Administration (FDA) released a new draft guidance titled “Expedited Program for Serious…
Read More
Beneficial regeneration dual method through Hexun exosomes to transfer heat

Beneficial regeneration dual method through Hexun exosomes to transfer heat

2024-08-16
Benefiting from Taiwan’s major breakthroughs in the cell therapy market this year, including the Ministry of Health and Welfare’s conditional…
Read More
FDA promotes AI technology program

FDA promotes AI technology program

2024-07-26
The Artificial Intelligence Program at the FDA’s Center for Devices and Radiological Health (CDRH) is one of the 20 research…
Read More
Event Review-2024 Shanghai Medical Device Product Overseas Commercialization Conference

Event Review-2024 Shanghai Medical Device Product Overseas Commercialization Conference

2024-07-19
Vice President Thomas Jaw of VCRO Shanghai was invited as a lecturer for the event. He provided an overview of…
Read More
Taipei Medical University Registration Office Recruitment for Credit Program in Clinical Trials

Taipei Medical University Registration Office Recruitment for Credit Program in Clinical Trials

2024-07-12
The objectives of the program are: To train students to become familiar with the principles, regulations, design, and practice related…
Read More
Great news! TCR-T Cell therapy for HPV-related solid tumors has received FDA approval for Phase I/II clinical trials.

Great news! TCR-T Cell therapy for HPV-related solid tumors has received FDA approval for Phase I/II clinical trials.

2024-07-05
VCRO’s professional team assisted in preparing the submission to the US FDA for a clinical trial of client’s TCR-T cell…
Read More
FDA Promotes Clinical Trial Innovation

FDA Promotes Clinical Trial Innovation

2024-06-27
The U.S. Food and Drug Administration (FDA) is committed to promoting clinical trial innovation to accelerate the development of new…
Read More
Congratulations! FDA has approved Phase I clinical trials for the treatment of EGFR mutant NSCLC with small molecule pharmaceuticals.

Congratulations! FDA has approved Phase I clinical trials for the treatment of EGFR mutant NSCLC with small molecule pharmaceuticals.

2024-06-21
In Jun 2024, the professional team from VCRO assisted the client in submitting the clinical trial application of their small…
Read More
Congrats! Assistance in developing small molecule drugs for Alzheimer disease has acquired US FDA approval for Phase I human clinical trials

Congrats! Assistance in developing small molecule drugs for Alzheimer disease has acquired US FDA approval for Phase I human clinical trials

2024-06-12
VCRO’s professional team assisted our client’s small molecule drug product in submitting a clinical trial application for Alzheimer’s disease to…
Read More

What we do

Service Scope

VCRO has been in the market for 28 years, providing a complete one-stop service from IND to NDA. From medical affairs, regulatory affairs, clinical operations, data management and statistics, to EDC remote electronic data capture systems and IWRS, VCRO supports a complete service structure with more than 600 case experience and has delivered 54+ US FDA IND and 98+ GCP inspection.

54+ US FDA IND

Cell therapy, CAR-T, LBP, Gene therapy, nucleic acid drugs , miRNA , NCE , 505b2……

The counters

Full Service Capability

VCRO is extremely confident that we can customize the scope of services for you based on your needs and achieve project success.

0+

Therapeutic Area

+

Clinical Trial

0+

US FDA IND

+

GCP Inspection